This is not just another tool to image cancer. The probe is a two-for-one: detect cancer and distinguish one type from another. Together, they develop a cancer fingerprint.
Determining the presence of cancer, as well as its type and malignancy, is a stressful process for patients that can take up to two weeks to get a diagnosis. With a new bit of technology—a sugar-transporting biosensor—researchers at Michigan Technological University hope to reduce that timeframe down to minutes.
A collaborative team of chemists and engineers from Michigan Tech lays the groundwork for this vision in two new papers. In the Royal Society of Chemistry’s journal Chemical Communication (DOI: 10.1039/c7cc09809j), the team explains the basic science behind multicolor probes that enable targeting of a cancer-relevant fructose transporter, delving into the image-based detection of cancer cells. In the journal Biosensors (DOI: 10.3390/bios8020039), the team addresses applications for breast cancer detection and differentiating nonmalignant, pre-malignant and malignant cancer cells.
GLUT5 transports fructose and cancer loves sugar
Two Michigan Tech researchers collaborated on the studies. Marina Tanasova, assistant professor of chemistry, and Smitha Rao, assistant professor of biomedical engineering, turned a 10-minute office meeting into a two-year collaboration built on a tiny fluorescent probe that seeks out the fructose transporter named GLUT5.
Cells need carbohydrates; facilitative glucose transporters (GLUTs) bring nutrients in and out of cells. When metabolic swings kick in—say, from cancer development—the overall make-up of GLUTs change so that more or less GLUTs are active. Fructose transporters like GLUT5 are of particular interest because of the direct connection between fructose uptake and cancer development, which also changes as cancer progresses and becomes malignant.
In their Chemical Communications paper, Tanasova and Rao’s team report on the design and validation of the fluorescent probes, called ManCous, to observe GLUT5 activity in a cell. They document the multicolored fluorescence that distinguishes GLUT5-rich cells from those deficient in GLUT5. The follow up Biosensors paper provides a proof-of-principle use of these probes as tools to assess and compare GLUT5 and metabolic activity of different cell types, including normal cells and different cancer subtypes.
“We came closer to a basic screening of cells’ GLUT composition—one that both detects cancer and distinguishes type,” Tanasova says, adding that while the concept is elegant, developing the technology is not easy. “From basic science to application, there is a lot of transformation that has to happen.”
Engineering better cancer detection takes collaboration
By better understanding the science behind sugar transporters, the team is more equipped to build technology that captures an accurate and precise GLUT fingerprint of cancerous cells.
“This probe is like a Swiss army knife,” Rao says, explaining that cancer detection is not the only use for the probe. “The more we learn about cancer through these probes, the more opportunities we have to apply them—which means more chances to treat different cancers, hopefully cure them, and at least prevent their spread and maximize drug delivery.”
What makes the probe so versatile is its ability to not only seek out and highlight cancer cells, but also to reveal the metabolic nuances of different stages of cancer development. While cancer generally gobbles up fructose, the GLUT5 and metabolic activity of nonmalignant, pre-malignant and malignant breast cancer cells do vary, which is what Rao, Tanasova and their team explored in the Biosensors paper. They found that ManCou probes allow for parallel analysis and quantification of GLUT5 and metabolic activity of cells just after a 10-minute incubation period. The notable differences in fluorescence intensity observed between normal cells and cancer cells, as well as different cancer types, provide important points of differentiation between different cell types and make these probes promising tools for cancer detection and diagnostics.
The Latest on: Cancer fingerprint
via Google News
The Latest on: Cancer fingerprint
- Cancer as Weapon: Poppy Bush’s Radioactive War on Iraq on December 7, 2018 at 1:18 am
Most of the leukemia and cancer victims aren’t soldiers ... let’s not forget that Bush’s fingerprints are all over the October Surprise of 1980, when emissaries from the Reagan campaign convinced the ... […]
- ‘Universal fingerprint’ in cancer DNA points to potential blood test. But it’s not ready for patients on December 5, 2018 at 10:00 am
A ‘universal cancer test’ is big news today, with headlines claiming that the test will be able to detect any cancer in just 10 minutes. While the science behind the headlines is exciting, the reality ... […]
- Patient data base could help doctors be proactive withe cancer patients on December 4, 2018 at 7:29 pm
"total cancer care" seeks to provide more information, options and enhanced care for patients. He said about 600 patients are added weekly. Dalton said all patients are different, like fingerprints di... […]
- Qld researchers develop ten minute cancer test on December 4, 2018 at 5:35 pm
The research found a “universal fingerprint” in the DNA of common cancers that ... Researchers demonstrated that there is a tell-tale pattern of gene expression in cancer genomes which is not found in ... […]
- Cheap, fast universal test promises to revolutionize cancer detection on December 4, 2018 at 4:32 pm
Plenty of promising work into identifying the genetic fingerprint of cancerous tumors ... DNA biomarker that can point to all kinds of cancer has been elusive. The new Australian research focused ... […]
- DNA ‘fingerprint’ brings prospect of fast test for cancer on December 4, 2018 at 3:01 pm
A “universal fingerprint” has been found in the DNA of common cancers that could one day enable a diagnosis to be made with a simple ten-minute blood test. Researchers demonstrated that there is a tel... […]
- DNA and fingerprints data shared with other countries for first time on December 2, 2018 at 5:30 pm
Access to our DNA database and automated fingerprint information system by other states will ... Irish priest who died of cancer at 36 put on first step of path to sainthood Susan Gately An Irish prie... […]
- The Biology of Sugars Points to a Sweet Strategy for Treating Cancer on November 28, 2018 at 5:07 am
Palleon launched in 2015 on the strength of research by a handful of labs suggesting that structured patterns of cell-surface glycans—a molecular fingerprint on virtually all cells—might hold the key ... […]
via Bing News